These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25689069)

  • 1. Manifestations of perihepatic lymph nodes in acute flare of chronic hepatitis B: association with HBeAg status and with HBeAg seroconversion.
    Ko YL; Sun CS; Chung KM; Lin YM; Feng IC; Sheu MJ; Koay LB; Lin CY; Ho CH; Kuo HT
    PLoS One; 2015; 10(2):e0117590. PubMed ID: 25689069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perihepatic nodes detected by point-of-care ultrasound in acute hepatitis and acute-on-chronic liver disease.
    Feng IC; Wang SJ; Sheu MJ; Koay LB; Lin CY; Ho CH; Sun CS; Kuo HT
    World J Gastroenterol; 2015 Nov; 21(44):12620-7. PubMed ID: 26640338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
    Hsu YS; Chien RN; Yeh CT; Sheen IS; Chiou HY; Chu CM; Liaw YF
    Hepatology; 2002 Jun; 35(6):1522-7. PubMed ID: 12029639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice.
    Lin B; Ha NB; Liu A; Trinh HN; Nguyen HA; Nguyen KK; Ahmed A; Keeffe EB; Garcia RT; Garcia G; Nguyen MH
    J Gastroenterol Hepatol; 2013 May; 28(5):855-60. PubMed ID: 23278507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBeAg seroconversion in children infected during early childhood with hepatitis B virus.
    Roushan MR; Bijani A; Ramzaninejad S; Roushan MH; Amiri MJ; Baiani M
    J Clin Virol; 2012 Sep; 55(1):30-3. PubMed ID: 22727680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A scoring model predicts hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with nucleos(t)ide analogs: real-world clinical practice.
    Geng M; Li Y; Gao F; Sun L; Yang X; Wang R; Chen J; Zhang Q; Wan G; Wang X
    Int J Infect Dis; 2017 Sep; 62():18-25. PubMed ID: 28669850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and meta-analysis: Development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis e antigen seroconversion.
    Zhou TC; Lai X; Feng MH; Tang Y; Zhang L; Wei J
    J Viral Hepat; 2018 Oct; 25(10):1172-1179. PubMed ID: 29741285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection.
    Liaw YF; Lau GK; Kao JH; Gane E
    Dig Dis Sci; 2010 Oct; 55(10):2727-34. PubMed ID: 20238245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversion.
    Lau GK
    Liver Int; 2010 Apr; 30(4):512-20. PubMed ID: 20102511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tfh cell-mediated humoral immune response and HBsAg level can predict HBeAg seroconversion in chronic hepatitis B patients receiving peginterferon-α therapy.
    Zhang L; Zhang M; Li H; Chen Z; Luo A; Liu B; Chen M; Peng M; Ren H; Hu P
    Mol Immunol; 2016 May; 73():37-45. PubMed ID: 27037894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.
    Yang HC; Chen CL; Shen YC; Peng CY; Liu CJ; Tseng TC; Su TH; Chuang WL; Yu ML; Dai CY; Liu CH; Chen PJ; Chen DS; Kao JH
    Hepatology; 2013 Mar; 57(3):934-43. PubMed ID: 23112104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between HBeAg seroconversion with genotypes and HBV specific CTL in patients with chronic hepatitis B treated with Adefovir dipivoxil].
    Zhou YL; Wang XC; Wu YT; Tan YF; Zhao YP; Tang JM; Pan JQ; Yang ZX; Gu XB
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):220-3. PubMed ID: 21977598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B.
    Chen YC; Chu CM; Liaw YF
    Hepatology; 2010 Feb; 51(2):435-44. PubMed ID: 19918971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of seasonal variation on the clinical course of chronic hepatitis B.
    Zhang SJ; Chen ZX; Jiang KP; Wu WK; Zhang CY; Gu YL
    J Gastroenterol; 2006 Nov; 41(11):1107-15. PubMed ID: 17160522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The duration of lamivudine therapy for chronic hepatitis B: cessation vs. continuation of treatment after HBeAg seroconversion.
    Fung J; Lai CL; Tanaka Y; Mizokami M; Yuen J; Wong DK; Yuen MF
    Am J Gastroenterol; 2009 Aug; 104(8):1940-6; quiz 1947. PubMed ID: 19455108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term lamivudine therapy in patients with chronic hepatitis B.
    Chien RN; Liaw YF
    Intervirology; 2003; 46(6):362-6. PubMed ID: 14688453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal study of hepatitis activity and viral replication before and after HBeAg seroconversion in chronic hepatitis B patients infected with genotypes B and C.
    Yuen MF; Fung SK; Tanaka Y; Kato T; Mizokami M; Yuen JC; Wong DK; Yuan HJ; Sum SM; Chan AO; Wong BC; Lai CL
    J Clin Microbiol; 2004 Nov; 42(11):5036-40. PubMed ID: 15528692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients.
    Idilman R; Cinar K; Seven G; Bozkus Y; Elhan A; Bozdayi M; Yurdaydin C; Bahar K
    J Viral Hepat; 2012 Mar; 19(3):220-6. PubMed ID: 22329377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion.
    Yuen MF; Wong DK; Zheng BJ; Chan CC; Yuen JC; Wong BC; Lai CL
    J Viral Hepat; 2007 Apr; 14(4):269-75. PubMed ID: 17381719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.